The first enterobacter cloacae co-producing NDM and OXA-48 carbapenemases and interhospital spread of OXA-48 and NDM-producing klebsiella pneumoniae in Turkey

Clinical Laboratory

Volumn 63, Issue 7-8, 2017, Pages 1213-1222

  Haciseyitoglu, Demet ^a   Dokutan, Aysegul ^a   Abulaila, Ayham ^a   Erdem, Fatma ^a   Cag, Yasemin ^b   Ozer, Serdar ^b   Aktas, Zerrin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Department of Infectious Diseases and Clinical Microbiology ^*  (Turkey)

Author keywords

Carbapenemase; Enterobacteriaceae; NDM; OXA 48

Indexed keywords

AMIKACIN; CARBAPENEMASE; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CATHETER; CEREBROSPINAL FLUID; CLONAL VARIATION; ENTEROBACTER CLOACAE; IMP GENE; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; KPC GENE; MINIMUM INHIBITORY CONCENTRATION; NDM 1 GENE; NONHUMAN; OXA 48 GENE; POLYMERASE CHAIN REACTION; SPUTUM; TRACHEAL ASPIRATION PROCEDURE; TURKEY (REPUBLIC); URINE; VIM GENE; WOUND; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; TURKEY (BIRD);

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; ENTEROBACTER CLOACAE; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; TURKEY;

EID: 85029150646     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2017.170120     Document Type: Article

References (29)

1. Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mai Infect 2014; 44:51-6 (PMID: 24360201).
2. Tangden T, Giske CG. Global dissemination of extensively drugresistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med 2015; 277:501-12 (PMID: 25556628).
3. Bratu S, Tolaney P, Karumudi U, et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005; 56:128-32 (PMID: 15917285).
4. Kontopidou F, Giamarellou H, Katerelos P, et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect 2014; 20:O117-23 (PMID: 23992130).
5. Vardakas KZ, Matthaiou DK, Falagas ME, Antypa E, Koteli A, Antoniadou E. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. J Infect 2015; 70:592-9 (PMID: 25447713).
6. Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. CClin Microbiol Infect 2011; 17:1798-803 (PMID: 215 95793).
7. Performance Standarts for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational supplement. 2014. http://microbiolab-bg.com/wp-content/uploads/2015/05/CLSI-2014.pdf
8. Pankey GA Tigecycline. J Antimicrob Chemother 2005; 56:470-80 (PMID: 16040625).
9. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009; 53:333-4 (PMID: 19015-350).
10. Aktas Z, Kayacan ÇB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy 2008; 54:101-6 (PMID: 18303258).
11. Overdevest IT, Willemsen I, Elberts S, et al. Evaluation of the DiversiLab typing method in a multicenter study assessing horizontal spread of highly resistant gram-negative rods. J Clin Microbiol 2011; 49:3551-4 (PMID: 21865432).
12. Guler I, Kilic H, Atalay MA, Percin D, Ercal BD. [Genotyping of nosocomial methicillin-resistant Staphylococcus aureus strains isolated from clinical specimens by rep-PCR]. Mikrobiyol Bui 2011; 45:581-91 (PMID: 22090288).
13. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-96 (PMID: 23969216).
14. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009; 53:5046-54 (PMID: 19770275).
15. Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010; 15 (PMID: 21144431).
16. Mavroidi A, Liakopoulos A, Sarrou S, Miriagou V, Petinaki E. Identification and characterization of genetic structures coding for carbapenemases in Enterobacteria from Central Greece. Diagn Microbiol Infect Dis 2015; 81:47-9 (PMID: 25445118).
17. Voulgari E, Zarkotou O, Ranellou K, et al. Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother 2013; 68:84-8 (PMID: 22945916).
18. Alp E, Percin D, Colakoglu S, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey. J Hosp Infect 2013; 84:178-80 (PMID: 23623803).
19. Poirel L, Heritier C, Tolun V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48:15-22 (PMID: 146 93513).
20. Carrer A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother 2008; 52:2950-4 (PMID: 18519712).
21. Kilic A, Aktas Z, Bedir O, et al. Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteria-ceae isolates in Turkey. Ann Clin Lab Sci 2011; 41:161-6 (PMID: 21844575).
22. Nazik H, Ongen B, Ilktac M, et al. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey. Southeast Asian J Trop Med Public Health 2012; 43:1178-85 (PMID: 23431824).
23. Carrer A, Poirel L, Yilmaz M, et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother. 2010; 54:1369-73 (PMID: 20086157).
24. Cakar A, Akyon Y, Gur D, et al. [Investigation of carbapenemases in carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains isolated in 2014 in Turkey]. Mikrobiyol Bui 2016; 50:21-33 (PMID: 27058326).
25. Trevino M, Moldes L, Martinez-Lamas L, Varon C, Regueiro BJ. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain). Eur J Clin Microbiol Infect Dis 2009; 28:1253-8 (PMID: 19504135).
26. Pfeifer Y, Schlatterer K, Engelmann E, et al. Emergence of OXA-48-type carbapenemase-producing Enterobacteriaceae in German hospitals. Antimicrob Agents Chemother 2012; 56:2125-8 (PMID: 22290940).
27. Heller I, Grif K, Orth D. Emergence of VIM-1-carbapenemase-producing Enterobacter cloacae in Tyrol, Austria. J Med Microbiol 2012; 61:567-71 (PMID: 22194339).
28. Osterblad M, Kirveskari J, Hakanen AJ, Tissari P, Vaara M, Jalava J. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11). J Antimicrob Chemother 2012; 67:2860-4 (PMID: 22855858).
29. Poirel L, Yilmaz M, Istanbullu A, et al. Spread of NDM-1-pro-ducing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey. Antimicrob Agents Chemother 2014; 58:2929-33 (PMID: 24550328).